Skip to main
Skip to main
University-wide Navigation

Jill Turner Awarded Neuropharmacology Early Career Award

Jill Turner, a University of Kentucky College of Pharmacy assistant professor was recently awarded the American Society for Pharmacology and Experimental Therapeutics (ASPET) Neuropharmacology Early Career Award for 2021.

UKCOP Researchers Discuss the Potential Benefit of Azithromycin in Fighting COVID-19 Related Inflammation

Drs. Vince Venditto and David Feola have been studying the immunomodulatory effects of the antimicrobial drug azithromycin in the context of diseases in which inflammation drives part of the pathology including pneumonia, spinal cord injury, and heart attack.

UK Pharmacist Part of Committee to Better Serve Patients with Heart Conditions

According to the Centers for Disease Control and Prevention (CDC), in the United States more than 450,000 people are hospitalized each year due to a condition called atrial fibrillation, or AFib. AFib can cause chest pains, shortness of breath, irregular heartbeat, and ultimately increases the risk of stroke. While there are a variety of treatments for AFib, the American College of Cardiology Oversight Committee recently published an updated medication decision pathway for management of anticoagulation for AFib, venous thromboembolism (VTE), and other heart conditions.

UKCOP Researchers Receive $3M in Funding to Develop Treatments to Combat Ewing Sarcoma

A group of University of Kentucky College of Pharmacy researchers received $3 million in NIH funding to develop new treatments to combat the rare cancer Ewing sarcoma. Because cancer research is such a massive field spanning across different disciplines, UKCOP researchers decided to utilize team science to approach the project.

UK Grad Student Receives NIH F31 Award for a project started with UK IRC pilot funding

UK College of Pharmacy graduate student Kaitlind Howard received a competitive grant from the National Institutes of Health for a project that previously received pilot funding from the UK Igniting Research Collaborations program.

Prisinzano Named New Director of UK’s Center for Pharmaceutical Research and Innovation

Thomas Prisinzano, Ph.D., professor in the Department of Pharmaceutical Sciences, has been named director of the Center for Pharmaceutical Research and Innovation (CPRI). Prisinzano replaces former Director Jon Thorson, who was recently promoted to associate dean of research in the University of Kentucky College of Pharmacy.

UK HealthCare Study Uncovers Quality of Medication

UK HealthCare is one of only two known pharmacy groups examining and testing incoming medications for dispensing for quality, purity, and potential contamination. A recent drug study revealed that several vials in their contents had impurities greater than 6 times the amount allowed by the United States Pharmacopeia.

Research Publications - November 2020

The November 2020 publications from the University of Kentucky College of Pharmacy are now live. If you're your recent publication has been missed, please send the ADR's Office the citation to be added to the next month's list.

Research Publications - October 2020

The October 2020 publications from the University of Kentucky College of Pharmacy are now live. If you're your recent publication has been missed, please send the ADR's Office the citation to be added to the next month's list.

UK College of Pharmacy Collaboration Results in $2.9 Million Grant to Advance Epilepsy Research

Björn Bauer and a team of six co-investigators recently received $2.9 million from the National Institutes of Health to support their mission to find therapeutic strategies to resolve neurovascular inflammation and repair blood-brain barrier dysfunction in epilepsy.

We wish to remember and honor those who inhabited this Commonwealth before the arrival of the Europeans. Briefly occupying these lands were the Osage, Wyndott tribe, and Miami peoples. The Adena and Hopewell peoples, who are recognized by the naming of the time period in which they resided here, were here more permanently. Some of their mounds remain in the Lexington area, including at UK’s Adena Park.

In more recent years, the Cherokee occupied southeast Kentucky, the Yuchi southwest Kentucky, the Chickasaw extreme western Kentucky and the Shawnee central Kentucky including what is now the city of Lexington. The Shawnee left when colonization pushed through the Appalachian Mountains. Lower Shawnee Town ceremonial grounds are still visible in Greenup County.

We honor the first inhabitants who were here, respect their culture, and acknowledge the presence of their descendants who are here today in all walks of life including fellow pharmacists and healthcare professionals.